Most Popular
-
1
Controversial US YouTuber faces travel ban, police investigation
-
2
Pyongyang to bolster readiness against nuclear retaliation: Choe
-
3
SK Innovation becomes Asia-Pacific's largest energy firm after merger
-
4
Korean serial killer 'haunted by victims' ghosts' in prison, TV show reveals
-
5
Yoon's approval rating falls to 19%, all-time low: survey
-
6
No typhoons recorded in S. Korea for the first time in 7 years
-
7
[Robert Fouser] Accepting migrants in South Korea
![[Robert Fouser] Accepting migrants in South Korea](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/10/31/20241031050896_0.jpg&u=)
-
8
Samsung CEO calls for unrivaled technological leadership
-
9
Babymonster showcases YG-style hip hop with 1st LP ‘Drip’
-
10
Allies say 1953 mutual defense treaty extends to cyber, space threats
![[Robert Fouser] Accepting migrants in South Korea](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/10/31/20241031050896_0.jpg&u=)
GeneOne Life Science wins EMA nod for phase 2 clinical study of COVID-19 treatment
By Shim Woo-hyunPublished : Nov. 1, 2021 - 16:33
GeneOne Life Science’s investigational oral drug for COVID-19 has received regulatory approvals from the European Medicines Agency and Bulgaria to conduct a phase 2 clinical trial in Bulgaria, the Korean biotech firm said Monday.
The Balkan nation is among the five regions where GeneOne Life Science plans to conduct phase 2 studies of GLS-1027. It is also the last of the five to give the company a go-ahead. The four others are the US, South Korea, Puerto Rico and North Macedonia.
GeneOne Life Science plans to confirm GLS-1027’s therapeutic effect on a total of 132 patients infected with COVID-19 and its variants through safety and efficacy tests.
GLS-1027 is being developed as an oral pill that could suppress severe pneumonia caused by COVID-19 infection.
In animal tests, it showed therapeutic effects on pneumonia caused by the coronavirus.
GeneOne Life Science hopes that the drug candidate could also be applied to treat other autoimmune diseases.
![[Herald Review] ‘Amazon Bullseye,’ motley comedy of forced empathy, outdated wordplay](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/11/01/20241101050706_0.jpg&u=20241101194716)
